Tomokazu Ohishi

Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 54

Top Venues

International journal of molecular sciences

Molecules (Basel, Switzerland)

Monoclonal antibodies in immunodiagnosis and immunotherapy

Nature communications

Institute of Microbial Chemistry

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Microbial Chemistry

Japan

Senior Researcher

Publications

Mika K Kaneko, Hiroyuki Suzuki, Tomokazu Ohishi, Takuro Nakamura, Tomohiro Tanaka, Yukinari Kato
A Cancer-Specific Monoclonal Antibody against HER2 Exerts Antitumor Activities in Human Breast Cancer Xenograft Models. International journal of molecular sciences 25 (3) (2024)
Mika K Kaneko, Hiroyuki Suzuki, Tomokazu Ohishi, Takuro Nakamura, Tomohiro Tanaka, Yukinari Kato
A Cancer-Specific Monoclonal Antibody against HER2 Exerts Antitumor Activities in Human Breast Cancer Xenograft Models. International journal of molecular sciences 25 (3) (2024)
Hiroyuki Suzuki, Tomokazu Ohishi, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato
Anti-HER2 Cancer-Specific mAb, H 2 Mab-250-hG 1 , Possesses Higher Complement-Dependent Cytotoxicity than Trastuzumab. International journal of molecular sciences 25 (15) (2024)
Mika K Kaneko, Hiroyuki Suzuki, Tomokazu Ohishi, Takuro Nakamura, Tomohiro Tanaka, Yukinari Kato
A Cancer-Specific Monoclonal Antibody against HER2 Exerts Antitumor Activities in Human Breast Cancer Xenograft Models. International journal of molecular sciences 25 (3) (2024)
Mika K Kaneko, Hiroyuki Suzuki, Tomokazu Ohishi, Takuro Nakamura, Tomohiro Tanaka, Yukinari Kato
A Cancer-Specific Monoclonal Antibody against HER2 Exerts Antitumor Activities in Human Breast Cancer Xenograft Models. International journal of molecular sciences 25 (3) (2024)
Kenichiro Ishikawa, Hiroyuki Suzuki, Tomokazu Ohishi, Guanjie Li, Tomohiro Tanaka, Manabu Kawada, Akira Ohkoshi, Mika K Kaneko, Yukio Katori, Yukinari Kato
Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas. International journal of molecular sciences 25 (17) (2024)
Mika K Kaneko, Hiroyuki Suzuki, Tomokazu Ohishi, Takuro Nakamura, Tomohiro Tanaka, Yukinari Kato
A Cancer-Specific Monoclonal Antibody against HER2 Exerts Antitumor Activities in Human Breast Cancer Xenograft Models. International journal of molecular sciences 25 (3) (2024)
Hiroyuki Suzuki, Tomokazu Ohishi, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato
Anti-HER2 Cancer-Specific mAb, H 2 Mab-250-hG 1 , Possesses Higher Complement-Dependent Cytotoxicity than Trastuzumab. International journal of molecular sciences 25 (15) (2024)
Mika K Kaneko, Hiroyuki Suzuki, Tomokazu Ohishi, Takuro Nakamura, Tomohiro Tanaka, Yukinari Kato
A Cancer-Specific Monoclonal Antibody against HER2 Exerts Antitumor Activities in Human Breast Cancer Xenograft Models. International journal of molecular sciences 25 (3) (2024)
Hiroki Tanabe, Takuji Suzuki, Tomokazu Ohishi, Mamoru Isemura, Yoriyuki Nakamura, Keiko Unno
Effects of Epigallocatechin-3-Gallate on Matrix Metalloproteinases in Terms of Its Anticancer Activity. Molecules (Basel, Switzerland) 28 (2) (2023)
Hiroyuki Suzuki, Tomokazu Ohishi, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato
A Cancer-Specific Monoclonal Antibody against Podocalyxin Exerted Antitumor Activities in Pancreatic Cancer Xenografts. International journal of molecular sciences 25 (1) (2023)
Shohei Takase, Takashi Hiroyama, Fumiyuki Shirai, Yuki Maemoto, Akiko Nakata, Mayumi Arata, Seiji Matsuoka, Takeshi Sonoda, Hideaki Niwa, Shin Sato, Takashi Umehara, Mikako Shirouzu, Yosuke Nishigaya, Tatsunobu Sumiya, Noriaki Hashimoto, Ryosuke Namie, Masaya Usui, Tomokazu Ohishi, Shun-Ichi Ohba, Manabu Kawada, Yoshihiro Hayashi, Hironori Harada, Tokio Yamaguchi, Yoichi Shinkai, Yukio Nakamura, Minoru Yoshida, Akihiro Ito
A specific G9a inhibitor unveils BGLT3 lncRNA as a universal mediator of chemically induced fetal globin gene expression. Nature communications 14 (1) (2023)
Tomohiro Tanaka, Hiroyuki Suzuki, Tomokazu Ohishi, Mika K Kaneko, Yukinari Kato
Antitumor activities against breast cancers by an afucosylated anti-HER2 monoclonal antibody H 2 Mab-77-mG 2a -f. Cancer science (2023)
Hiroyuki Suzuki, Tomokazu Ohishi, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato
A Cancer-Specific Monoclonal Antibody against Podocalyxin Exerted Antitumor Activities in Pancreatic Cancer Xenografts. International journal of molecular sciences 25 (1) (2023)
Tomokazu Ohishi, Mika K Kaneko, Yukihiro Yoshida, Atsuo Takashima, Yukinari Kato, Manabu Kawada
Current Targeted Therapy for Metastatic Colorectal Cancer. International journal of molecular sciences 24 (2) (2023)
Takuji Suzuki, Tomokazu Ohishi, Hiroki Tanabe, Noriyuki Miyoshi, Yoriyuki Nakamura
Anti-Inflammatory Effects of Dietary Polyphenols through Inhibitory Activity against Metalloproteinases. Molecules (Basel, Switzerland) 28 (14) (2023)
Shohei Takase, Takashi Hiroyama, Fumiyuki Shirai, Yuki Maemoto, Akiko Nakata, Mayumi Arata, Seiji Matsuoka, Takeshi Sonoda, Hideaki Niwa, Shin Sato, Takashi Umehara, Mikako Shirouzu, Yosuke Nishigaya, Tatsunobu Sumiya, Noriaki Hashimoto, Ryosuke Namie, Masaya Usui, Tomokazu Ohishi, Shun-Ichi Ohba, Manabu Kawada, Yoshihiro Hayashi, Hironori Harada, Tokio Yamaguchi, Yoichi Shinkai, Yukio Nakamura, Minoru Yoshida, Akihiro Ito
A specific G9a inhibitor unveils BGLT3 lncRNA as a universal mediator of chemically induced fetal globin gene expression. Nature communications 14 (1) (2023)
Shohei Takase, Takashi Hiroyama, Fumiyuki Shirai, Yuki Maemoto, Akiko Nakata, Mayumi Arata, Seiji Matsuoka, Takeshi Sonoda, Hideaki Niwa, Shin Sato, Takashi Umehara, Mikako Shirouzu, Yosuke Nishigaya, Tatsunobu Sumiya, Noriaki Hashimoto, Ryosuke Namie, Masaya Usui, Tomokazu Ohishi, Shun-Ichi Ohba, Manabu Kawada, Yoshihiro Hayashi, Hironori Harada, Tokio Yamaguchi, Yoichi Shinkai, Yukio Nakamura, Minoru Yoshida, Akihiro Ito
A specific G9a inhibitor unveils BGLT3 lncRNA as a universal mediator of chemically induced fetal globin gene expression. Nature communications 14 (1) (2023)
Hiroyuki Suzuki, Tomokazu Ohishi, Ren Nanamiya, Manabu Kawada, Mika K Kaneko, Yukinari Kato
Defucosylated Monoclonal Antibody (H 2 Mab-139-mG 2a -f) Exerted Antitumor Activities in Mouse Xenograft Models of Breast Cancers against Human Epidermal Growth Factor Receptor 2. Current issues in molecular biology 45 (10) (2023)
Hiroki Tanabe, Takuji Suzuki, Tomokazu Ohishi, Mamoru Isemura, Yoriyuki Nakamura, Keiko Unno
Effects of Epigallocatechin-3-Gallate on Matrix Metalloproteinases in Terms of Its Anticancer Activity. Molecules (Basel, Switzerland) 28 (2) (2023)
Hiroyuki Suzuki, Tomokazu Ohishi, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato
A Cancer-Specific Monoclonal Antibody against Podocalyxin Exerted Antitumor Activities in Pancreatic Cancer Xenografts. International journal of molecular sciences 25 (1) (2023)
Shohei Takase, Takashi Hiroyama, Fumiyuki Shirai, Yuki Maemoto, Akiko Nakata, Mayumi Arata, Seiji Matsuoka, Takeshi Sonoda, Hideaki Niwa, Shin Sato, Takashi Umehara, Mikako Shirouzu, Yosuke Nishigaya, Tatsunobu Sumiya, Noriaki Hashimoto, Ryosuke Namie, Masaya Usui, Tomokazu Ohishi, Shun-Ichi Ohba, Manabu Kawada, Yoshihiro Hayashi, Hironori Harada, Tokio Yamaguchi, Yoichi Shinkai, Yukio Nakamura, Minoru Yoshida, Akihiro Ito
A specific G9a inhibitor unveils BGLT3 lncRNA as a universal mediator of chemically induced fetal globin gene expression. Nature communications 14 (1) (2023)
Daisuke Tatsuda, Masahide Amemiya, Chisato Nosaka, Ryuichi Sawa, Hideyuki Muramatsu, Masayuki Igarashi, Junjiro Yoshida, Tomokazu Ohishi, Manabu Kawada
Two new adenopeptins B and C inhibit sphere formation of pancreatic cancer cells. The Journal of antibiotics (2023)
Tomokazu Ohishi, Mika K Kaneko, Yukihiro Yoshida, Atsuo Takashima, Yukinari Kato, Manabu Kawada
Current Targeted Therapy for Metastatic Colorectal Cancer. International journal of molecular sciences 24 (2) (2023)
Tomokazu Ohishi, Mika K Kaneko, Yukihiro Yoshida, Atsuo Takashima, Yukinari Kato, Manabu Kawada
Current Targeted Therapy for Metastatic Colorectal Cancer. International journal of molecular sciences 24 (2) (2023)
Hiroki Tanabe, Takuji Suzuki, Tomokazu Ohishi, Mamoru Isemura, Yoriyuki Nakamura, Keiko Unno
Effects of Epigallocatechin-3-Gallate on Matrix Metalloproteinases in Terms of Its Anticancer Activity. Molecules (Basel, Switzerland) 28 (2) (2023)
Hiroyuki Suzuki, Tomokazu Ohishi, Mika K Kaneko, Yukinari Kato
A Humanized and Defucosylated Antibody against Podoplanin (humLpMab-23-f) Exerts Antitumor Activities in Human Lung Cancer and Glioblastoma Xenograft Models. Cancers 15 (20) (2023)
Hiroki Tanabe, Takuji Suzuki, Tomokazu Ohishi, Mamoru Isemura, Yoriyuki Nakamura, Keiko Unno
Effects of Epigallocatechin-3-Gallate on Matrix Metalloproteinases in Terms of Its Anticancer Activity. Molecules (Basel, Switzerland) 28 (2) (2023)
Tomokazu Ohishi, Mika K Kaneko, Yukihiro Yoshida, Atsuo Takashima, Yukinari Kato, Manabu Kawada
Current Targeted Therapy for Metastatic Colorectal Cancer. International journal of molecular sciences 24 (2) (2023)
Teizo Asano, Tomohiro Tanaka, Hiroyuki Suzuki, Guanjie Li, Tomokazu Ohishi, Manabu Kawada, Takeo Yoshikawa, Mika K Kaneko, Yukinari Kato
A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG 2a -f) Exerts Antitumor Activity in Xenograft Model. Antibodies (Basel, Switzerland) 11 (4) (2022)
Tomokazu Ohishi, Noriyuki Miyoshi, Mari Mori, Miki Sagara, Yukio Yamori
Health Effects of Soy Isoflavones and Green Tea Catechins on Cancer and Cardiovascular Diseases Based on Urinary Biomarker Levels. Molecules (Basel, Switzerland) 27 (24) (2022)
Guanjie Li, Hiroyuki Suzuki, Junko Takei, Teizo Asano, Masato Sano, Tomohiro Tanaka, Hiroyuki Harada, Takuya Mizuno, Tomokazu Ohishi, Manabu Kawada, Mika K Kaneko, Yukinari Kato
Antitumor Activities in Mouse Xenograft Models of Canine Mammary Gland Tumor by Defucosylated Mouse-Dog Chimeric Anti-Epidermal Growth Factor Receptor Antibody (E134Bf). Monoclonal antibodies in immunodiagnosis and immunotherapy 41 (2) (2022)
Tomokazu Ohishi, Sumio Hayakawa, Noriyuki Miyoshi
Involvement of microRNA modifications in anticancer effects of major polyphenols from green tea, coffee, wine, and curry. Critical reviews in food science and nutrition (2022)
Teizo Asano, Tomohiro Tanaka, Hiroyuki Suzuki, Guanjie Li, Tomokazu Ohishi, Manabu Kawada, Takeo Yoshikawa, Mika K Kaneko, Yukinari Kato
A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG 2a -f) Exerts Antitumor Activity in Xenograft Model. Antibodies (Basel, Switzerland) 11 (4) (2022)
Tomokazu Ohishi, Noriyuki Miyoshi, Mari Mori, Miki Sagara, Yukio Yamori
Health Effects of Soy Isoflavones and Green Tea Catechins on Cancer and Cardiovascular Diseases Based on Urinary Biomarker Levels. Molecules (Basel, Switzerland) 27 (24) (2022)
Yasukiyo Yoshioka, Tomokazu Ohishi, Yoriyuki Nakamura, Ryuuta Fukutomi, Noriyuki Miyoshi
Anti-Cancer Effects of Dietary Polyphenols via ROS-Mediated Pathway with Their Modulation of MicroRNAs. Molecules (Basel, Switzerland) 27 (12) (2022)
Tomohiro Tanaka, Tomokazu Ohishi, Masaki Saito, Hiroyuki Suzuki, Mika K Kaneko, Manabu Kawada, Yukinari Kato
Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Exerted Antitumor Activities in Mouse Xenograft Models of Canine Mammary Gland Tumor. Monoclonal antibodies in immunodiagnosis and immunotherapy 41 (3) (2022)
Teizo Asano, Tomohiro Tanaka, Hiroyuki Suzuki, Guanjie Li, Tomokazu Ohishi, Manabu Kawada, Takeo Yoshikawa, Mika K Kaneko, Yukinari Kato
A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG 2a -f) Exerts Antitumor Activity in Xenograft Model. Antibodies (Basel, Switzerland) 11 (4) (2022)
Sumio Hayakawa, Tomokazu Ohishi, Yumiko Oishi, Mamoru Isemura, Noriyuki Miyoshi
Contribution of Non-Coding RNAs to Anticancer Effects of Dietary Polyphenols: Chlorogenic Acid, Curcumin, Epigallocatechin-3-Gallate, Genistein, Quercetin and Resveratrol. Antioxidants (Basel, Switzerland) 11 (12) (2022)
Tomokazu Ohishi, Takayuki Hishiki, Mirza S Baig, Sajjan Rajpoot, Uzma Saqib, Tomohiko Takasaki, Yukihiko Hara
Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2. PloS one 17 (7) (2022)
Hiroyuki Suzuki, Teizo Asano, Tomokazu Ohishi, Takeo Yoshikawa, Hiroyoshi Suzuki, Takuya Mizuno, Tomohiro Tanaka, Manabu Kawada, Mika K Kaneko, Yukinari Kato
Antitumor Activities in Mouse Xenograft Models of Canine Fibroblastic Tumor by Defucosylated Mouse-Dog Chimeric Anti-HER2 Monoclonal Antibody (H77Bf). Monoclonal antibodies in immunodiagnosis and immunotherapy (2022)
Tomokazu Ohishi, Noriyuki Miyoshi, Mari Mori, Miki Sagara, Yukio Yamori
Health Effects of Soy Isoflavones and Green Tea Catechins on Cancer and Cardiovascular Diseases Based on Urinary Biomarker Levels. Molecules (Basel, Switzerland) 27 (24) (2022)
Ren Nanamiya, Tomokazu Ohishi, Hiroyuki Suzuki, Takuya Mizuno, Takeo Yoshikawa, Teizo Asano, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato
Defucosylated Mouse-Dog Chimeric Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody (H77Bf) Exerts Antitumor Activities in Mouse Xenograft Models of Canine Osteosarcoma. Monoclonal antibodies in immunodiagnosis and immunotherapy (2022)
Tomokazu Ohishi, Noriyuki Miyoshi, Mari Mori, Miki Sagara, Yukio Yamori
Health Effects of Soy Isoflavones and Green Tea Catechins on Cancer and Cardiovascular Diseases Based on Urinary Biomarker Levels. Molecules (Basel, Switzerland) 27 (24) (2022)
Hiroki Kawabata, Hiroyuki Suzuki, Tomokazu Ohishi, Manabu Kawada, Mika K Kaneko, Yukinari Kato
A Defucosylated Mouse Anti-CD10 Monoclonal Antibody (31-mG 2a -f) Exerts Antitumor Activity in a Mouse Xenograft Model of CD10-Overexpressed Tumors. Monoclonal antibodies in immunodiagnosis and immunotherapy 41 (2) (2022)
Nami Tateyama, Hiroyuki Suzuki, Tomokazu Ohishi, Teizo Asano, Tomohiro Tanaka, Takuya Mizuno, Takeo Yoshikawa, Manabu Kawada, Mika K Kaneko, Yukinari Kato
Antitumor Activity of an Anti-EGFR/HER2 Bispecific Antibody in a Mouse Xenograft Model of Canine Osteosarcoma. Pharmaceutics 14 (11) (2022)
Hiroki Kawabata, Tomokazu Ohishi, Hiroyuki Suzuki, Teizo Asano, Manabu Kawada, Hiroyoshi Suzuki, Mika K Kaneko, Yukinari Kato
A Defucosylated Mouse Anti-CD10 Monoclonal Antibody (31-mG 2a -f) Exerts Antitumor Activity in a Mouse Xenograft Model of Renal Cell Cancers. Monoclonal antibodies in immunodiagnosis and immunotherapy (2022)
Sumio Hayakawa, Tomokazu Ohishi, Yumiko Oishi, Mamoru Isemura, Noriyuki Miyoshi
Contribution of Non-Coding RNAs to Anticancer Effects of Dietary Polyphenols: Chlorogenic Acid, Curcumin, Epigallocatechin-3-Gallate, Genistein, Quercetin and Resveratrol. Antioxidants (Basel, Switzerland) 11 (12) (2022)
Nohara Goto, Hiroyuki Suzuki, Tomokazu Ohishi, Akiko Harakawa, Guanjie Li, Masaki Saito, Junko Takei, Tomohiro Tanaka, Teizo Asano, Masato Sano, Manabu Kawada, Mika K Kaneko, Yukinari Kato
Antitumor Activities in Mouse Xenograft Models of Canine Fibroblastic Tumor by Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody. Monoclonal antibodies in immunodiagnosis and immunotherapy 41 (2) (2022)
Ryuuta Fukutomi, Tomokazu Ohishi, Yu Koyama, Monira Pervin, Yoriyuki Nakamura, Mamoru Isemura
Beneficial Effects of Epigallocatechin-3-O-Gallate, Chlorogenic Acid, Resveratrol, and Curcumin on Neurodegenerative Diseases. Molecules (Basel, Switzerland) 26 (2) (2021)
Tomokazu Ohishi, Ryuuta Fukutomi, Yutaka Shoji, Shingo Goto, Mamoru Isemura
The Beneficial Effects of Principal Polyphenols from Green Tea, Coffee, Wine, and Curry on Obesity. Molecules (Basel, Switzerland) 26 (2) (2021)
Guanjie Li, Tomokazu Ohishi, Mika K Kaneko, Junko Takei, Takuya Mizuno, Manabu Kawada, Masaki Saito, Hiroyuki Suzuki, Yukinari Kato
Defucosylated Mouse-Dog Chimeric Anti-EGFR Antibody Exerts Antitumor Activities in Mouse Xenograft Models of Canine Tumors. Cells 10 (12) (2021)
Tomokazu Ohishi, Yukinari Kato, Mika K Kaneko, Shun-Ichi Ohba, Hiroyuki Inoue, Akiko Harakawa, Manabu Kawada
Anti-Metastatic Activity of an Anti-EGFR Monoclonal Antibody against Metastatic Colorectal Cancer with KRAS p.G13D Mutation. International journal of molecular sciences 21 (17) (2020)
Sumio Hayakawa, Tomokazu Ohishi, Noriyuki Miyoshi, Yumiko Oishi, Yoriyuki Nakamura, Mamoru Isemura
Anti-Cancer Effects of Green Tea Epigallocatchin-3-Gallate and Coffee Chlorogenic Acid. Molecules (Basel, Switzerland) 25 (19) (2020)

Tomokazu Ohishi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tomokazu Ohishi